Search results
Phantom Cell Lines Undermine Cancer Research Credibility
Medscape· 1 day agoThis superficiality was illustrated by an image, created by artificial intelligence, of a mouse with...
Cracked Heels Causing You Pain? We Can Help
Runner s World· 6 days agoBacteria can then enter those cracks, leading to a skin infection known as cellulitis. If you’re bothered by cracked heels, it’s essential to figure out...
MONECO Advisors LLC Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 1 day agoMONECO Advisors LLC trimmed its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 11.2% during the fourth quarter, HoldingsChannel reports. The firm owned 1,741 shares of the medical research ...
AI Enhances Readability of Cancer Information for Patients
Medscape· 2 days agoChatGPT improved the readability of cancer-related information on patient-facing websites, without...
Solving RLS: Largest Genetic Study to Date May Help
Medscape· 5 days agoFor decades, scientists have been trying to unravel the mysteries of restless legs syndrome (RLS), a poorly understood and underdiagnosed neurological...
Spartan Planning & Wealth Management Sells 194 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoSpartan Planning & Wealth Management cut its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 15.3% in the fourth quarter, according to the company in its most recent disclosure ...
175 Shares in Amgen Inc. (NASDAQ:AMGN) Acquired by Livelsberger Financial Advisory
ETF DAILY NEWS· 1 day agoLivelsberger Financial Advisory purchased a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The ...
Vanguard Group Inc. Acquires 6,572 Shares of Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoVanguard Group Inc. boosted its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission ...
Amgen (NASDAQ:AMGN) Price Target Raised to $332.00 at Royal Bank of Canada
ETF DAILY NEWS· 4 days agoAmgen (NASDAQ:AMGN – Free Report) had its target price hoisted by Royal Bank of Canada from $328.00 to $332.00 in a research report sent to investors on Friday, Benzinga reports. Several other ...
Greenwood Capital Associates LLC Has $6.10 Million Stock Holdings in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 2 days agoGreenwood Capital Associates LLC reduced its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 0.2% in the 4th quarter, Holdings Channel reports. The institutional investor owned 21,173 ...